Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Telmisatan 80mg and S-Amlodipine 2.5mg as a Fixed Dose Combination Tablet Compared With Combination Therapy in Healthy Volunteers
Latest Information Update: 01 Feb 2011
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Amlodipine; Telmisartan
- Indications Essential hypertension
- Focus Pharmacokinetics
- 18 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2010 New trial record